BRIEF-Medicinova gets notice of allowance for new patent covering MN-001 and MN-002 for treatment of Fibrosis

Medicinova: * Receives notice of allowance for brand-new patent covering
MN-001 and MN-002 for treatment of Fibrosis

* Says as soon as provided, patent maturing from this permitted patent
application is anticipated to expire no earlier than June 2035

Source text for Eikon:

Further company coverage:

( Bengaluru Newsroom: +1 -646 -223 -8780).

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *